15-34794656-CG-CGG
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_005159.5(ACTC1):c.129+23dupC variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00451 in 1,607,318 control chromosomes in the GnomAD database, including 308 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_005159.5 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACTC1 | ENST00000290378.6 | c.129+23_129+24insC | intron_variant | Intron 2 of 6 | 1 | NM_005159.5 | ENSP00000290378.4 | |||
GJD2-DT | ENST00000503496.6 | n.300-15840_300-15839insG | intron_variant | Intron 2 of 2 | 2 | |||||
ACTC1 | ENST00000560563.2 | n.235+23_235+24insC | intron_variant | Intron 2 of 5 | 2 | |||||
GJD2-DT | ENST00000671663.1 | n.95-15840_95-15839insG | intron_variant | Intron 1 of 1 |
Frequencies
GnomAD3 genomes AF: 0.0241 AC: 3665AN: 152152Hom.: 159 Cov.: 32
GnomAD3 exomes AF: 0.00593 AC: 1400AN: 236080Hom.: 65 AF XY: 0.00421 AC XY: 545AN XY: 129356
GnomAD4 exome AF: 0.00245 AC: 3559AN: 1455048Hom.: 147 Cov.: 31 AF XY: 0.00211 AC XY: 1529AN XY: 723124
GnomAD4 genome AF: 0.0242 AC: 3685AN: 152270Hom.: 161 Cov.: 32 AF XY: 0.0226 AC XY: 1680AN XY: 74466
ClinVar
Submissions by phenotype
not specified Benign:4
Variant summary: ACTC1 c.129+23dupC is located at a position not widely known to affect splicing. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.0059 in 236080 control chromosomes, predominantly at a frequency of 0.09 within the African or African-American subpopulation in the gnomAD database, including 64 homozygotes. The observed variant frequency within African or African-American control individuals in the gnomAD database is significantly higher than the estimated maximal expected allele frequency for a pathogenic variant in ACTC1 causing Hypertrophic Cardiomyopathy phenotype (2.5e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. To our knowledge, no occurrence of c.129+23dupC in individuals affected with Hypertrophic Cardiomyopathy and no experimental evidence demonstrating its impact on protein function have been reported. One submitter has cited clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as benign. Based on the evidence outlined above, the variant was classified as benign. -
- -
- -
- -
not provided Benign:2
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at